Loading organizations...
Loading organizations...
Immune cell therapy company targeting solid tumors.
Neowise has raised $28.7M across 1 funding round.
Neowise has raised $28.7M in total across 1 funding round.
Neowise has raised $28.7M in total across 1 funding round.
Neowise's investors include Delian Capital, GEM, Sun Yuandong.
Neowise has raised $28.7M across 1 funding round. Most recently, it raised $28.7M Series B in January 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 26, 2026 | $28.7M Series B | Delian Capital, GEM, Sun Yuandong |